Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications
about
Cytoprotective-selective activated protein C therapy for ischaemic strokeIncreased coagulation and suppressed generation of activated protein C in aged mice during intra-abdominal sepsis.A novel heparin-dependent inhibitor of activated protein C that potentiates consumptive coagulopathy in Russell's viper envenomation.Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice.A Novel Protein C Mutation Causing Neonatal Purpura Fulminans.
P2860
Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Severe congenital protein C de ...... g blood-clotting complications
@en
Severe congenital protein C deficiency: the use of protein C concentrates
@nl
type
label
Severe congenital protein C de ...... g blood-clotting complications
@en
Severe congenital protein C deficiency: the use of protein C concentrates
@nl
prefLabel
Severe congenital protein C de ...... g blood-clotting complications
@en
Severe congenital protein C deficiency: the use of protein C concentrates
@nl
P2860
P356
P1476
Severe congenital protein C de ...... g blood-clotting complications
@en
P2093
Paul N Knoebl
P2860
P304
P356
10.2147/BTT.S1954
P50
P577
2008-06-01T00:00:00Z